Assessment of Left Atrial Size and Function by Cardiac Magnetic Resonance (ALATRIUM)

April 27, 2026 updated by: Istituto Auxologico Italiano

Assessment of Left Atrial Size and Function by Cardiac Magnetic Resonance: the ALATRIUM Study

Left atrial (LA) size and function are powerful prognostic markers in a variety of clinical conditions. Cardiac magnetic resonance (CMR) is considered the gold-standard to assess the volumes of heart chambers by contouring cavity borders at end-diastole and end-systole from a short-axis cine stack. This method is routinely used to measure ventricular volumes and ejection fraction, but has never been implemented for LA volume measurements, due to the need of a significant lengthening of both CMR acquisition and post-processing times. Current CMR guidelines do not provide any specific recommendation on LA imaging in daily routine, and LA volume is usually evaluated by using the biplane area-length algorithm in standard cine long-axis images. Yet, the latter methodology implies geometric assumptions about the LA shape that are often not fulfilled in routine patients. Moreover, the standard long-axis views are oriented according to the major axis of the left ventricle (LV), which lies in a plane with a different spatial orientation compared with the LA. As a result, standard long-axis views optimized according to the maximal LV length commonly foreshorten the LA and therefore underestimate its size.

Accordingly, a previous echocardiographic study showed that long-axis views focused on the LA were more accurate to derive LA maximal volume vs. standard long-axis views.

Differently from echocardiography, CMR allows to orientate images during acquisition process with no dependency from acoustic windows. Capturing the true LA long-axis by focused imaging is therefore more feasible with CMR vs. two-dimensional echocardiography. Compared to current CMR practice, implementation of focused LA long-axis views might result in improved accuracy of LA volumes estimation with no significant delay on acquisition times (Figure).

LA dysfunction, as assessed by deformation analysis, is emerging as an early prognostic marker in several cardiac diseases. At present, standard long-axis cine images are used for CMR feature tracking (CMR-FT), which allows the assessment of atrial phasic functions. Of core importance, CMR-FT derived strain parameters [i.e., LA total strain (εs), conduit strain (εe), and booster strain (εa)] are sensible to plan orientation and might be affected by foreshortening.

Current CMR protocols use long-axis cine images oriented on the LV long axis and may systematically underestimate LA size and function. We hypothesize that LA-focused long-axis cine images at CMR are more accurate in estimating LA volumes and function than current practice.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • San Donato Milanese, Italy, 20100
        • Policlinico San Donato, IRCCS

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

Patients who undergo clinically indicated CMR

Description

Inclusion Criteria:

  • Older than 18 years
  • Clinically indicated CMR with diagnostic image quality
  • Signed informed consent

Exclusion Criteria:

  • Unwillingness to participate in the study
  • Congenital heart disease
  • Pregnancy or breast-feeding
  • Any other contraindication to CMR study
  • Heart transplantation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Clinically indicated CMR
Patients who undergo clinically indicated CMR
CMR image acquisition and analysis of the left atrium

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Left atrial volume - focused long-axis views
Time Frame: Baseline
Left atrial volume obtained by focused long-axis imaging
Baseline
Left atrial volume - standard long axis views
Time Frame: Baseline
Left atrial volume obtained by standard long-axis imaging
Baseline
Duration of acquisition of focused long-axis views of left atrium
Time Frame: Baseline
Duration of acquisition of focused long-axis views of left atrium in minutes
Baseline
Longitudinal strain - focused long-axis views
Time Frame: Baseline
CMR Feature Tracking (CMR-FT) strain obtained by focused long-axis imaging
Baseline
Longitudinal strain - standard long-axis views
Time Frame: Baseline
CMR Feature Tracking (CMR-FT) strain obtained by standard long-axis imaging
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 25, 2021

Primary Completion (Actual)

August 25, 2025

Study Completion (Actual)

August 25, 2025

Study Registration Dates

First Submitted

April 16, 2026

First Submitted That Met QC Criteria

April 27, 2026

First Posted (Actual)

May 1, 2026

Study Record Updates

Last Update Posted (Actual)

May 1, 2026

Last Update Submitted That Met QC Criteria

April 27, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 09C124

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe